Slocum, Gordon & Co’s Colgate-Palmolive CL Stock Holding History

Slocum, Gordon & Co’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$308K	Hold	3,360	–	–	0.2%	53
2026 Q1	$286K	Sell	3,360 -9,013	-73%	-$803K	0.19%	49
2025 Q4	$978K	Sell	12,373 -8,523	-41%	-$668K	0.71%	37
2025 Q3	$1.67M	Sell	20,896 -1,050	-5%	-$89.6K	1.33%	25
2025 Q2	$1.99M	Sell	21,946 -435	-2%	-$39.7K	1.61%	20
2025 Q1	$2.1M	Sell	22,381 -645	-3%	-$57.8K	1.56%	23
2024 Q4	$2.09M	Buy	23,026 +19,100	+487%	+$1.82M	1.72%	18
2024 Q3	$408K	Sell	3,926 -23,690	-86%	-$2.41M	0.16%	43
2024 Q2	$2.68M	Sell	27,616 -200	-0.7%	-$18.4K	1.99%	18
2024 Q1	$2.5M	Sell	27,816 -715	-3%	-$60.6K	1.86%	18
2023 Q4	$2.27M	Sell	28,531 -150	-0.5%	-$11.3K	2%	16
2023 Q3	$2.04M	Buy	28,681 +24,235	+545%	+$1.81M	1.78%	18
2023 Q2	$343K	Hold	4,446	–	–	0.25%	39
2023 Q1	$334K	Hold	4,446	–	–	0.28%	38
2022 Q4	$350K	Buy	+4,446	New	+$333K	0.23%	41

Other funds holding CL

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PAM

PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

JIC

Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return

Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Slocum, Gordon & Co's CL Position: Q2 2026 in Review

Slocum, Gordon & Co held its Colgate-Palmolive (CL) position steady in Q2 2026 at 3,360 shares worth $308K. The position accounts for 0.2% of the portfolio, ranked #53.

Slocum, Gordon & Co first reported a position in CL in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.68M in Q2 2024. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Slocum, Gordon & Co held 3,360 shares of Colgate-Palmolive worth $308K as of Q2 2026.
Slocum, Gordon & Co left its Colgate-Palmolive share count unchanged in Q2 2026.
Colgate-Palmolive made up 0.2% of Slocum, Gordon & Co's portfolio in Q2 2026, its #53 holding.
Slocum, Gordon & Co first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 15 quarters since.
Slocum, Gordon & Co's Colgate-Palmolive position peaked at $2.68M in Q2 2024.
597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Slocum, Gordon & Co's 13F filing for Q2 2026, filed 23 Jul 2026.